Jingyao Liang

10PUBLICATIONS
9CO-AUTHORS
Adolescent healthCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 21, 2025
Effectiveness and safety of age-based dosing of abrocitinib in children and adolescents with moderate to severe atopic dermatitis: A two-center, prospective real-world study in China.

Jingyao Liang, Hui Ye, Jun Wang

|Dec 11, 2024
Combined Abrocitinib and Acitretin Therapy for Darier's Disease: A Case Report.

Hui Ye, Weifeng Chen, Wenyan Liu

|Feb 06, 2024
Oral abrocitinib in the treatment of granuloma annulare: a case report.

Wenyan Liu, Weifeng Chen, Xin Tian

|Jul 02, 2021
Secukinumab-induced multiple lentigines in areas of resolved psoriatic plaques: A case report and literature review.

Sanquan Zhang, Jingyao Liang, Xin Tian

|Feb 11, 2021
Circular RNA profiles and the potential involvement of down-expression of hsa_circ_0001360 in cutaneous squamous cell carcinogenesis.

Pingjiao Chen, Changxing Li, Hongchang Huang

|Jul 30, 2020
Secukinumab monotherapy successfully treated severe refractory type V (atypical juvenile) pityriasis rubra pilaris: A case report and literature review.

Jing-Yao Liang, Rui-Xian Ye, Xin Tian

Pageof 2

Frequent Collaborators

5 joint publications

Xibao Zhang

2 joint publications

Rui-Xian Ye

2 joint publications

Hui Ye

1 joint publications

Qiongxiao Huang